Wanbury Ltd

Wanbury Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Wanbury Ltd

₹ 192 1.60%
24 Jul - close price
wanbury.com BSE: 524212 NSE: WANBURY
About

Incorporated in 1988, Wanbury Ltd is in the business of pharmaceutical and related activities, including research[1]

Key Points

Business Overview:[1]
WL is a pharmaceutical company with a presence in the API global market and domestic branded Formulation. It’s majorly into Active Pharmaceutical Ingredient (API) Sales & Marketing in over 50 countries and Pan-India
Formulation presence

Website BSE NSE
  • Market Cap ₹ 629 Cr.
  • Current Price ₹ 192
  • High / Low ₹ 202 / 48.9
  • Stock P/E 20.6
  • Book Value ₹ 8.54
  • Dividend Yield 0.00 %
  • ROCE 58.1 %
  • ROE %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has delivered good profit growth of 26.6% CAGR over last 5 years

Cons

  • Stock is trading at 22.5 times its book value
  • The company has delivered a poor sales growth of 8.04% over past five years.
  • Contingent liabilities of Rs.1,072 Cr.
  • Promoters have pledged 76.7% of their holding.
  • Earnings include an other income of Rs.28.6 Cr.
  • Company's cost of borrowing seems high

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
120 128 124 125 134 117 124 126 133 146 144 146 139
122 121 117 116 122 120 118 119 119 133 127 124 121
Operating Profit -2 7 7 9 13 -3 6 6 14 13 17 21 18
OPM % -1% 5% 6% 7% 10% -3% 5% 5% 11% 9% 12% 15% 13%
1 0 0 0 77 2 1 0 -3 1 1 1 26
Interest 6 5 5 6 5 3 4 7 8 6 8 8 7
Depreciation 3 3 3 3 3 3 3 3 3 3 3 3 3
Profit before tax -9 -1 -1 0 82 -7 -1 -3 1 5 7 10 34
Tax % 0% 7% 11% 14% -1% -3% 25% 8% -11% 6% -2% -0% 1%
-9 -1 -1 0 83 -7 -1 -3 1 5 7 10 34
EPS in Rs -3.58 -0.26 -0.18 0.11 25.27 -2.21 -0.27 -1.00 0.31 1.43 2.25 3.14 10.27
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Sep 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
459 661 250 420 432 370 391 367 392 511 500 576
491 637 228 387 414 438 375 344 374 475 476 506
Operating Profit -32 25 21 33 19 -68 16 23 18 36 23 70
OPM % -7% 4% 9% 8% 4% -18% 4% 6% 5% 7% 5% 12%
5 -78 6 0 90 76 9 84 2 77 0 29
Interest 37 48 19 32 36 31 40 33 23 21 21 29
Depreciation 23 23 5 9 10 10 10 10 10 11 12 13
Profit before tax -87 -125 4 -7 62 -32 -25 65 -12 81 -10 56
Tax % 0% 2% 28% 0% 1% -1% -1% 0% 2% -0% 1% 1%
-87 -128 3 -7 62 -32 -25 64 -13 81 -10 56
EPS in Rs -50.19 -63.95 1.60 -3.58 26.71 -13.49 -10.48 25.79 -5.04 24.94 -3.18 17.09
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 8%
3 Years: 14%
TTM: 15%
Compounded Profit Growth
10 Years: %
5 Years: 27%
3 Years: 65%
TTM: 414%
Stock Price CAGR
10 Years: 22%
5 Years: 63%
3 Years: 30%
1 Year: 252%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: %

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Sep 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 17 20 20 20 23 24 24 25 25 33 33 33
Reserves -65 -212 -214 -209 -176 -208 -233 -168 -181 -56 -66 -5
415 389 381 362 300 250 260 190 192 100 95 116
406 209 209 215 265 207 236 232 253 276 242 199
Total Liabilities 773 406 396 388 412 273 286 279 289 353 304 343
423 174 164 180 186 178 172 164 167 167 167 167
CWIP 25 13 19 14 10 10 9 14 11 2 2 3
Investments 1 0 0 0 0 0 0 0 0 0 0 0
324 219 213 193 216 84 105 101 111 183 135 174
Total Assets 773 406 396 388 412 273 286 279 289 353 304 343

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Sep 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
87 68 40 43 43 32 30 44 17 41 20 4
-21 -6 -5 -20 -13 -1 -3 64 8 1 -9 -17
-64 -71 -30 -28 -27 -33 -27 -108 -17 -29 -32 15
Net Cash Flow 3 -9 5 -5 3 -2 -0 -0 7 13 -21 2

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Sep 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 67 57 144 65 71 29 41 50 32 45 50 57
Inventory Days 63 42 103 69 63 27 36 25 41 60 27 43
Days Payable 114 113 301 172 260 174 209 253 221 218 179 196
Cash Conversion Cycle 15 -14 -55 -38 -125 -118 -131 -177 -148 -113 -103 -96
Working Capital Days -159 -3 -26 -45 -132 -195 -175 -212 -168 -103 -100 -19
ROCE % -11% 4% 12% 57% -1% 26% 31% 27% 46% 17% 58%

Shareholding Pattern

Numbers in percentages

3 Recently
Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
39.90% 39.89% 39.89% 39.85% 39.85% 39.84% 39.84% 39.84% 39.80% 39.79% 39.79% 39.79%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.18% 0.22%
0.01% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
60.09% 60.11% 60.11% 60.15% 60.16% 60.16% 60.16% 60.16% 60.19% 60.20% 60.02% 59.97%
No. of Shareholders 11,58111,61911,28911,39811,55511,88811,91111,74111,63411,61613,08714,400

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings